Rachel Sexton

1.5k total citations · 1 hit paper
30 papers, 930 citations indexed

About

Rachel Sexton is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Rachel Sexton has authored 30 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Hematology. Recurrent topics in Rachel Sexton's work include Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (4 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Rachel Sexton is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (4 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Rachel Sexton collaborates with scholars based in United States and Japan. Rachel Sexton's co-authors include Asfar S. Azmi, Mohammed Najeeb Al Hallak, Maria Diab, Philip A. Philip, Steve Kim, Bart Barlogie, John Crowley, Antje Hoering, Md. Hafiz Uddin and Saad Z. Usmani and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rachel Sexton

29 papers receiving 908 citations

Hit Papers

Gastric cancer: a comprehensive review of current and fut... 2020 2026 2022 2024 2020 100 200 300 400

Peers

Rachel Sexton
Nicholas Davies United Kingdom
Daniel Triner United States
Sylvie Shen Australia
Suk‐young Lee South Korea
Jiao Ji China
Yun Hee Kang South Korea
Houda Alachkar United States
Rachel Sexton
Citations per year, relative to Rachel Sexton Rachel Sexton (= 1×) peers Renata Binato

Countries citing papers authored by Rachel Sexton

Since Specialization
Citations

This map shows the geographic impact of Rachel Sexton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Sexton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Sexton more than expected).

Fields of papers citing papers by Rachel Sexton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Sexton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Sexton. The network helps show where Rachel Sexton may publish in the future.

Co-authorship network of co-authors of Rachel Sexton

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Sexton. A scholar is included among the top collaborators of Rachel Sexton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Sexton. Rachel Sexton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Husain Yar, Misako Nagasaka, Yiwei Li, et al.. (2022). Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers. Cancer Research Communications. 2(5). 342–352. 21 indexed citations
2.
Sexton, Rachel, Husain Yar Khan, Yiwei Li, et al.. (2022). Correction to: Connecting the human microbiome and pancreatic cancer. Cancer and Metastasis Reviews. 41(2). 333–333. 1 indexed citations
3.
Sexton, Rachel, Md. Hafiz Uddin, Husain Yar Khan, et al.. (2022). Connecting the Human Microbiome and Pancreatic Cancer. Cancer and Metastasis Reviews. 41(2). 317–331. 18 indexed citations
4.
Khan, Husain Yar, Rachel Sexton, Srikant Viswanadha, et al.. (2020). Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth. Cancers. 12(3). 750–750. 28 indexed citations
5.
Sexton, Rachel, Mohammed Najeeb Al Hallak, Maria Diab, & Asfar S. Azmi. (2020). Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer and Metastasis Reviews. 39(4). 1179–1203. 481 indexed citations breakdown →
6.
Sexton, Rachel, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin, Maria Diab, & Asfar S. Azmi. (2020). Gastric Cancer Heterogeneity and Clinical Outcomes. Technology in Cancer Research & Treatment. 19. 1079203125–1079203125. 33 indexed citations
7.
Azmi, Asfar S., Amro Aboukameel, Mohammed Najeeb Al Hallak, et al.. (2020). Abstract 234: A novel, small molecule inhibitor of dihydroorotate dehydrogenase (DHODH), RP7214, potentiates activity of chemotherapeutics in breast and colorectal cancers. Cancer Research. 80(16_Supplement). 234–234. 4 indexed citations
8.
Nagasaka, Misako, et al.. (2019). Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer—A review. Critical Reviews in Oncology/Hematology. 145. 102841–102841. 36 indexed citations
9.
Sexton, Rachel, et al.. (2019). Ras and exosome signaling. Seminars in Cancer Biology. 54. 131–137. 50 indexed citations
10.
Sexton, Rachel, Amro Aboukameel, Husain Yar Khan, et al.. (2019). Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer. International Journal of Molecular Sciences. 20(19). 4826–4826. 32 indexed citations
11.
Sexton, Rachel, et al.. (2018). Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer. Scientific Reports. 8(1). 16008–16008. 22 indexed citations
12.
Valdivieso, Manuel, et al.. (2017). Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Wang, Beibei, Rachel Sexton, & Michael Feig. (2017). Kinetics of nucleotide entry into RNA polymerase active site provides mechanism for efficiency and fidelity. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1860(4). 482–490. 16 indexed citations
15.
Sanchorawala, Vaishali, Antje Hoering, David C. Seldin, et al.. (2013). Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115. Bone Marrow Transplantation. 48(12). 1537–1542. 19 indexed citations
16.
Usmani, Saad Z., Bijay Nair, Pingping Qu, et al.. (2012). Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols. Leukemia. 26(11). 2398–2405. 45 indexed citations
17.
Usmani, Saad Z., Rachel Sexton, Antje Hoering, et al.. (2012). Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance. Blood. 120(8). 1597–1600. 45 indexed citations
18.
Usmani, Saad Z., Rachel Sexton, John Crowley, & Bart Barlogie. (2011). Autologous Stem Cell Transplantation as a Care Option in Waldenström's Macroglobulinemia. Clinical Lymphoma Myeloma & Leukemia. 11(1). 139–142. 17 indexed citations
19.
Kurpakus‐Wheater, Michelle, et al.. (2003). Caspase-9 activation in hypoxic human corneal epithelial cells. APOPTOSIS. 8(6). 681–688. 9 indexed citations
20.
Weinberger, D.R., David W. Jones, Trey Sunderland, et al.. (1992). IN VIVO IMAGING OF CEREBRAL MUSCARINIC RECEPTORS WITH 1-123 QNB AND SPECT: STUDIES IN NORMAL SUBJECTS AND PATIENTS WITH DEMENTIA. Clinical Neuropharmacology. 15. 194A–195A. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026